Amber Hall

PHD Doctor of Philosophy,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Research Consulting Journal Manuscript

Areas Of Interest

Calcium Calmodulin Dependent Phosphodiesterase Cardiomyopathics, Lentiginosis Methylmercury Compounds Infection, Aspergillus Phenazine Methosulfate Bayer 2353 Mallows, Marsh Tumor Necrosis Factor Inhibitors Transcription Factor, NRF1 Type III Hyperlipoproteinemia CD64 Antigens Posterior Circulation Infarction, Brain Biosynthesis Termination, Protein Gnotobiotic Glomerular Basement Membrane Online Intervention Lymphangiogeneses Mapping, Restriction Blood Poisoning Enterobacteria phage N4 Hearing Synesthesia, Colored Keratinocyte Chromomycin A3 Synthase, Porphobilinogen Rennin Atrophy, Muscular, Spinobulbar Po 12 U2AF Splicing Factor E1A p60 Acute T-Lymphocytic Leukemias Ataxia, Locomotor Hymenolepis Infection Miniaturisation Atrophy, Pontoolivocerebellar vertigo neogama Caudatus Amomum Stress, Genotoxic Psychotic Mood Disorders

Professional Narrative

Dr. Amber Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Mayo Clinic 2010
Director Medicine, Mayo Clinic 2005

Education

Master of Science in physician assistant, Yale School of Medicine 2011
Doctor of medicine, Harvard Medical School 1990

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02